Document |
Document Title |
WO/2019/231155A1 |
The present invention relates to a novel compound having excellent luminescence and thermal stability, and an organic electroluminescent element comprising the compound in at least one organic material layer, thereby having improved char...
|
WO/2019/225166A1 |
The purpose of the present invention is to provide an active ester compound which can be used in a curable resin composition having excellent heat resistance and dielectric characteristics. The purpose of the present invention is also to...
|
WO/2019/225035A1 |
The compound represented by the general formula exhibits strong anti-allergy activity. R1 represents a substituted or unsubstituted acyloxy group, or a substituted or unsubstituted acylamino group. R2 represents a substituted or unsubsti...
|
WO/2019/224138A1 |
The invention relates to a method for producing compounds of formula (I), (I), based on compounds of formula (II), (II), wherein R1, R2 and R3 have the above meaning and wherein R1 and R3 do not simultaneously represent hydrogen in a com...
|
WO/2019/225742A1 |
Constructed is a technology capable of coupling organic compounds efficiently, inexpensively, simply, and in a short time by a small number of steps. A method for coupling organic compounds, wherein the method for coupling organic compou...
|
WO/2019/224027A1 |
A lubricant comprising 2,5-(bishydroxymethyl) tetryhydrofuran dialkanoates This invention relates to a lubricant comprising a THF ester of the formula (I) as defined below. This invention further relates to a use of the THF ester as lubr...
|
WO/2019/221513A1 |
The present invention relates to a novel brominated furanone derivative, a method for preparing same and a pharmaceutical composition containing same as an active ingredient. A novel brominated furanone derivative or pharmaceutically acc...
|
WO/2019/221210A1 |
Provided are a method for producing a carbamate, said method comprising the following steps (1) and (2), etc.: (1) a step for producing compound (A) having a urea bond by using an organic primary amine having at least one primary amino g...
|
WO/2019/218868A1 |
The present disclosure provides a compound, a complex, a preparation method thereof, and a use thereof. The compound is represented by the following structural formula, in which R1 to R10 are the same or different and are each independen...
|
WO/2019/221122A1 |
The present invention addresses the problem of providing a compound having a β-lactamase inhibitory activity. The problem is solved by a compound which is represented by general formula (1) that represents a compound in which a specific...
|
WO/2019/218418A1 |
Provided in the invention is a preparation method for synthesizing a photosensitive compound through a Claisen-Schmidt reaction. An aldehyde free of alpha-H and a ketone containing alpha-H are selected to be synthesized to obtain the pro...
|
WO/2019/222077A1 |
A method for producing an aromatic dianhydride includes reacting an aromatic diimide with a substituted or unsubstituted phthalic anhydride in an aqueous medium in the presence of an amine exchange catalyst to provide an aqueous reaction...
|
WO/2019/216743A1 |
The present invention provides a novel heterocyclic compound and an organic light emitting diode using same.
|
WO/2019/216411A1 |
Provided is an organic electroluminescent element comprising a compound that is represented by formula (1) and having a more improved lifetime. (In the formula, X, R1-R8, R11-R17, R21-R30, L1, L2, n, and Ar1-Ar3 are as defined in the des...
|
WO/2019/217257A1 |
A method for producing an aromatic dianhydride includes reacting an aromatic diimide with a substituted or unsubstituted phthalic anhydride in an aqueous medium in the presence of an amine exchange catalyst to provide an aqueous reaction...
|
WO/2019/214749A1 |
A method for synthesizing a benzofuran derivative by means of a non-metal Lewis acid catalyzing the addition of a C-O bond within an olefin molecule, comprising the following steps: step one, preparing an olefin: using a phenol derivativ...
|
WO/2019/215291A1 |
A compound of formula (I) or a pharmaceutically acceptable salt thereof.The compound is useful in therapy, e.g. for the treatment of a condition or disorder associated with nicotinamide adenine dinucleotide phosphate oxidase4 or 2 (Nox4o...
|
WO/2019/214576A1 |
The present invention relates to a method for preparing 2,5-furandicarboxylic acid, comprising reacting a furoate, a molten salt, and a catalyst under the condition of carbon dioxide gas, to obtain a 2,5-furandicarboxylate; subjecting th...
|
WO/2019/216600A1 |
The present invention relates to an oxime ester group-substituted aromatic compound, a preparation method therefor, and a photoresist composition comprising same and is useful for providing a photosensitive composition, which effectively...
|
WO/2019/211877A1 |
The present invention discloses a novel process for the preparation of macrocyclic ketone analogs of halichondrin B or pharmaceutically acceptable salts thereof and to novel intermediates which are produced during the course of carrying ...
|
WO/2019/210215A1 |
The present invention provides new prodrugs of therapeutically active loop diuretics, including oligomeric prodrugs, and compositions to treat medical disorders, for example, ocular disorders such as glaucoma, a disorder or abnormality r...
|
WO/2019/201718A1 |
Presently claimed invention relates to D-glucaro-6, 3-lactone monoester products and a process for the preparation of the same by reaction of D-glucaro-6, 3-lactone with at least one alcohol in the presence of at least one mineral acid o...
|
WO/2019/201569A1 |
A process for preparing dialkyl terephalate comprising the following steps:- i) providing furan-2,5-dicarboxylate; ii) esterifying the furan-2,5-dicarboxylate with alcohol to form furan-2,5-carboxylic acid dialkyl ester; iii) reacting th...
|
WO/2019/203430A1 |
The present invention relates to a novel compound and an organic electroluminescent device comprising same. As the compound according to the present invention is used for an organic material layer of an organic electroluminescent device,...
|
WO/2019/204442A1 |
Provided herein are compounds comprising a cyanoacrylamide moiety. Also provided herein are pharmaceutical compositions comprising such compounds, and methods of using such compounds and pharmaceutical compositions for inhibiting the pos...
|
WO/2019/199468A1 |
Disclosed herein are methods for synthesizing useful intermediates and/or products from 1,2,5,6-hexanetetrol (HTO), which itself can be derived from a sugar. In an aspect, a process is provided for production of THFDCA from 1,2,5,6-hexan...
|
WO/2019/198678A1 |
The present invention pertains to a lactone compound represented by general formula (A), and an ether compound represented by general formula (B). [In formula (A), R is a hydrogen atom or R1, R' is R1 if R is a hydrogen atom, carbon bond...
|
WO/2019/199459A1 |
In a process for producing a biphenyl carboxylic acid, alcohol, and/or ester, benzene or toluene is reacted with a furanyl compound having the formula (I) where R1 is -H, -CH3, -CHO, -CH2OH, -COOH or -COOR2 and R2 is an alkyl group havin...
|
WO/2019/199461A1 |
A process for producing bifuran and/or biphenyl dicarboxylic acids, alcohols, and/or esters comprises reacting one or more furanyl compounds having the formula (I), where each R1 is independently selected from the group consisting of -H,...
|
WO/2019/199570A1 |
Processes are disclosed for the synthesis of 2-substituted furan derivatives from a substrate having a carbonyl functional group (C=O), with hydroxy-substituted carbon atoms at alpha and beta positions, relative to the carbonyl functiona...
|
WO/2019/196898A1 |
Provided in the present invention are a 2-(2,2-diarylethyl)-cyclic amine derivative or salt, the synthesis thereof, and an application and composition thereof. Biological activity tests show that the 2-(2,2-diarylethyl)-cyclic amine deri...
|
WO/2019/194616A1 |
The present application relates to a compound of chemical formula 1 and an organic light emitting diode comprising same.
|
WO/2019/195118A1 |
Inhibitors of EYA3 -protein tyrosine phosphatase are provided herein, as well as pharmaceutical compositions and methods relating thereto.
|
WO/2019/193068A1 |
The present invention relates to a process for the synthesis of a carbon labeled organic compound containing a carbon labeled carboxyl group. The present invention also concerns the use of carbon labeled organic compounds containing a ca...
|
WO/2019/194298A1 |
An organic electroluminescence element having a negative electrode, a positive electrode, and an organic layer between the negative electrode and the positive electrode, wherein the organic layer contains a compound represented by formul...
|
WO/2019/194615A1 |
The present description provides a compound of chemical formula 1 and an organic electronic device comprising same.
|
WO/2019/194136A1 |
Provided are a photosensitive composition having an excellent sensitivity, a cured film, a method for manufacturing a color filter, a color filter, a solid-state imaging element, and an image display device. The photosensitive compositio...
|
WO/2019/186498A1 |
Fluoroalkenyl heterocyclic compounds having Formula (I) are described together with agronomic compositions containing said compounds having formula (I) and their use for the control of nematodes in agricultural crops.
|
WO/2019/190271A1 |
The present application relates to a novel compound and an organic light-emitting device comprising same, the novel compound according to one embodiment of the present invention being applied to an organic light-emitting device to allow ...
|
WO/2019/190270A1 |
The present application relates to a novel compound and an organic light-emitting device comprising same, the novel compound according to one embodiment of the present invention being applied to an organic light-emitting device to allow ...
|
WO/2019/185646A2 |
A process for oxidising a substrate selected from hydroxymethylfurfural (HMF), diformylfuran (DFF), hydroxymethylfurancarboxylic acid (HMFCA) and formylfurancarboxylic acid (FFCA). Said process comprises mixing said substrate with catala...
|
WO/2019/185870A1 |
The present invention relates to novel spirocyclic compounds which act as modulators of indoleamine 2,3-dioxygenase (IDO1) and to the use of said compounds in the prophylaxis and/or treatment of diseases or conditions mediated by indolea...
|
WO/2019/188717A1 |
The present invention addresses the problem of providing a compound which is capable of forming a radical polymerization initiator that exhibits excellent heat resistance and solubility. The present invention is a compound represented by...
|
WO/2019/182693A1 |
A 5,5'-Di-(protected)-2,2' -bifuran: wherein each R1 is independently an unsubstituted or substituted 5- or 6-member 1,3-dioxo-2-y1 ring radical. Processes for making the bifuran include coupling 2-(protected)-furfural. Processes for usi...
|
WO/2019/180627A1 |
The present invention relates to an improved asymmetric synthesis of alpha- (diarylmethyl) alkyl amines (hereafter referred to as the compound (1)) or its pharmaceutically acceptable salt and derivatives. The process comprises an unusual...
|
WO/2019/179346A1 |
The present invention belongs to the field of medicinal chemistry, relates to novel benzoic acid compounds I and II, and relates to the applications thereof in prevention and treatment or remission of cerebral ischemia or ischemia after ...
|
WO/2019/177314A1 |
Disclosed are a novel diacylglycerol lactone compound for improving immunity and inhibiting infection by promoting neutrophil movement, a preparation method therefor, and an immunostimulator containing same as an active ingredient. The d...
|
WO/2019/174176A1 |
The present invention relates to the field of pharmaceutical synthesis, and in particularly relates to a preparation method for a hexahydrofuro-furan-ol derivative, and an intermediate of the derivative and a preparation method therefor....
|
WO/2019/174750A1 |
The invention relates to a process for recovering one or more gibberellins from an aqueous medium, the process comprising (a) contacting said aqueous medium with an oil to obtain an aqueous phase and an oil phase, resulting in extraction...
|
WO/2019/175464A1 |
The present invention related to compounds of formula (I) wherein R1, R2, ring A and ring Bare as defined in the claims. The compounds are potent inhibitors of the sodium-calcium exchanger (NCX) and are useful in the treatment or prevent...
|